Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMRN | AMGN | GILD | BIIB | CELG |
| Company | Amarin Corp ADR | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.8800 | 270.63 | 66.58 | 198.97 | 108.01 |
| High | 0.8894 | 274.86 | 67.19 | 205.75 | 108.59 |
| Low | 0.8655 | 269.65 | 66.37 | 198.97 | 107.27 |
| Last | 0.8705 | 274.03 | 66.82 | 199.72 | 108.24 |
| Change | -0.0128 | +0.49 | -0.21 | +6.54 | +0.11 |
| % Change | -1.45% | +0.18% | -0.31% | +3.39% | +0.10% |
| Volume | 500,631 | 990,066 | 3,834,309 | 2,050,032 | 191,230,496 |
| 20-Day Average Volume | 1,283,527 | 2,095,513 | 6,242,909 | 1,199,252 | 16,188,930 |
| Previous Close | 0.8833 | 273.54 | 67.03 | 193.18 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 0.9527 | 271.62 | 69.07 | 202.07 | 108.17 |
| 20-Day Raw Stochastic | 8.26% | 49.45% | 14.68% | 38.22% | 63.25% |
| 20-Day Relative Strength | 42.47% | 49.63% | 33.06% | 40.74% | 64.69% |
| Weighted Alpha | -45.85 | +11.97 | -20.79 | -35.48 | +46.30 |
| Today's Opinion | 56% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 40% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 56% Sell | 24% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.78% since 04/17/24 | +3.94% since 04/17/24 | +0.21% since 04/17/24 | +4.18% since 04/17/24 | -1.97% since 11/13/19 |
| Low | 0.8593 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 107.27 on 11/20/19 |
| High | 0.9600 on 04/18/24 | 274.62 on 04/24/24 | 67.68 on 04/23/24 | 205.75 on 04/24/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | +1.58% since 03/22/24 | -0.62% since 03/22/24 | -7.63% since 03/22/24 | -8.21% since 03/22/24 | +5.14% since 10/18/19 |
| Low | 0.8339 on 03/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 1.1100 on 04/09/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 218.26 on 03/25/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -24.06% since 01/24/24 | -10.16% since 01/24/24 | -15.67% since 01/24/24 | -19.00% since 01/24/24 | +13.63% since 08/20/19 |
| Low | 0.8015 on 03/14/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 1.3700 on 01/30/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +14.86% since 10/24/23 | -0.60% since 10/24/23 | -14.18% since 10/24/23 | -20.59% since 10/24/23 | +14.14% since 05/20/19 |
| Low | 0.6510 on 11/01/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 1.3700 on 01/30/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 362,747 | 146,720,288 | 83,457,512 | 28,080,836 | 77,035,920 |
| Shares Outstanding, K | 410,672 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 306,910,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -59,110,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 74,710,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -5,780,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 1.98 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 02/29/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 9.96 | 13.18 | 10.99 |